Sep 27,2022

Oxford-based Optellum raises $14m in funding round

Optellum, an Oxford-based medtech company that provides an AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round. The investment will allow the company to scale its base, operations and commercial launches in the UK and USA, accelerate its research and development, and expand its platform into personalised therapy decisions, integrating imaging with molecular data, robotics, and liquid biopsies. This funding round was led by Mercia, with additional investors Intuitive Ventures and Black Opal Ventures. Existing investors including St John�s College in the University of Oxford, IQ Capital, and the family office of Sir Martin & Lady Audrey Wood also participated in this round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 10,2014

WellDoc raises $20 million from Merck GHI Fund, Windham

Baltimore, Maryland-based WellDoc, one of the earliest and best known mobile health companies focused on diabetes management, has landed a $20 million round of investment that includes contributions from Merck Global Health Innovation Fund and Windham Venture Partners. The announcement marks WellDoc's first round of institutional money -- the company has long relied on angel investors and debt -- and now reports total funding at north of $50 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 28,2014

London-based medtech startup Big Health raises $3.3m

Big Health, a London-based medtech startup, has secured 3.3 million in a Series A funding round led by Forward Partners and Index Ventures. The young company plans to use the fresh capital to support its upcoming US expansion.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Sep 10,2014

Glen Tullman Launches Livongo Health™ to Empower Consumers with Chronic Conditions to Live Better, Beginning with Diabetes

Livongo Health™, a consumer digital health company, launched today with a vision to empower people with chronic conditions to live better through the combined power of technology, real-time personalized information, and support from their chosen care team. The company secured initial funding from 7wire Ventures (run by Tullman and long-time partner Lee Shapiro) and a recent $10 million Series A funding round from General Catalyst Partners.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 28,2014

Vida raises $5 million for app-based health and wellness coaching

San Francisco-based mobile-enabled health coaching services company Vida has raised $5 million in its first round of funding from Aspect Ventures, Khosla Ventures, Yahoo Co-Founder Jerry Yang, Signia Venture Partners, The Valley Fund, Yahoo Chairman Maynard Webb, Silicon Valley Bank's Kevin Scott, and Skip Battle. The company also commercially launched its app direct-to-consumer health and wellness coaching services, which cost $15 a week. Vida connects its users to nutritionists, physicians, diabetes educators, nurses, and more via its iPhone app. Vida CEO and Founder Stephanie Tilenius told MobiHealthNews the company also plans to develop an Android app for its service in the future.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 11,2015

MediSafe Raises $6M In Series A Funding

According to a “Geektime” report, the Israeli mobile medication management company MediSafe , raised $6 million in Series A funding. The report outlines that Pitango Ventures and well as TriVentures participated in the round, which brings the total amount raised by the company to over $7 million. “Geektime” also reports that MediSafe rejected a $25 million acquisition offer earlier last year made by an unnamed medical data company.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 11,2015

Digital Health Startup mySugr Gets $4.8M To Make Diabetes “Suck Less”

mySugr is announcing a new seed funding raise — of $4.8 million from two new investors, Switzerland-based Roche Ventures and U.S.-based iSeed Ventures. Existing investor XLHealth, from Germany, also participated in the round. Total funding raised to date is around $5.8 million. What’s the new cash injection for? Serious scale — as befits the team’s missionary zeal to help more diabetes sufferers like themselves.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 04,2015

One Drop Raises $8M in Series A Funding

Informed Data Systems, a NYC and Austin, TX-based digital consumer health company, raised $8m in Series A funding. Led by Jeff Dachis, CEO and Founder, Informed Data Systems provides One Drop, a diabetes management software, hardware and services platform. The round was led by RRE Ventures with participation from BoxGroup, LAUNCH Fund, Capital Factory and Neu Ventures. In conjunction with the funding, Stuart Ellman, managing partner at RRE Ventures, will join Informed Data Systems’ board of directors. The company intends to use the funds to continue expansion on the development of its platform and accelerate adoption among users, self-insured employers, and insurers.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 10,2016

Constant Therapy gets $2M for cognitive analysis app

Constant Therapy, an e-therapy app for patients suffering from head injuries, announced today that it has raised $2 million in Series A funding led by Golden Seeds with participation from Kapor Capital, Launchpad Venture Group, Pond Capital, and Community Health Network of Connecticut.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Apr 07,2016

Sweetch Health Raises $3.5M From OurCrowd And Philips

Israeli digital health startup Sweetch Health, which has developed a “digital vaccine” for diabetes, has raised $3.5 million in a Series A round led by OurCrowd, a leading equity crowdfunding platform, and Philips, a leading health technology company. Participation from prior investors also included Pontifax L.P. and Lionbird L.P. Sweetch Health has developed a revolutionary platform that assists in identifying individuals at risk of developing diabetes and coaching to prevent diabetes and other chronic conditions. Current funding will be used to complete a pilot program and clinical trials soon to begin at a major international medical institution and jump start commercialization in the USA.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES A